PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-435

  1. 685 Posts.
    lightbulb Created with Sketch. 130
    agreed, i struggled to understand the forecast P&L's too - either they are outright wrong or I'm missing something. Anyone got insight?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.